Stockreport

Zealand Pharma Shares Jump 17% After Positive Trial Results For Ozempic Competitor [Forbes]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF loss drug the company said could compete against Novo Nordisk's Ozempic and Eli Lilly's Mounjaro. The Danish pharmaceutical firm said its new weight loss drug could co [Read more]